e854248d-698b-4fff-b09f-59e294d079be
Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus.Mechanisms of ocular angiogenesis and its molecular mediators.Straylight measurements as an indication for cataract surgery.CD34 marks angiogenic tip cells in human vascular endothelial cell cultures.COmplement factor 3a alters proteasome function in human RPE cells and in animal model of age-related RPE degeneration.HIV-Associated Neuroretinal Disorder in Patients With Well-Suppressed HIV-InfectionQuality factor based correction for SD-OCT measurements in cataract patientsEffect of age on individual retinal layer thickness in normal eyes as measured with spectral-domain optical coherence tomography.Straylight measurements in contact lens wear.Neovascular age-related macular degeneration without drusen in the fellow eyeProtection against methylglyozal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology.Recent advances in ophthalmic molecular imagingVEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes.Differential TGF-beta signaling in retinal vascular cells: a role in diabetic retinopathy.Vitamin K supplementation increases vitamin K tissue levels but fails to counteract ectopic calcification in a mouse model for pseudoxanthoma elasticum.Antiplatelet and anticoagulant drugs do not affect visual outcome in neovascular age-related macular degeneration in the BRAMD trialStem Cell Derived Retinal Pigment EpitheliumPlasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier LossEndothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapy.Orthogonal polarization spectral imaging of conjunctival microcirculationVitreous TIMP-1 levels associate with neovascularization and TGF-beta2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy.Connective tissue growth factor is involved in structural retinal vascular changes in long-term experimental diabetesOptical density filters modeling media opacities cause decreased SD-OCT retinal layer thickness measurements with inter- and intra-individual variationNew approaches for the treatment of diabetic macular oedema: recommendations by an expert panel.A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes.Association of Genetic Variants With Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular DegenerationMolecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.Standardised disturbance of the optical coherence tomography signal has varying effects on the scan quality assessment when comparing four devices.Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edemaComparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular EdemaComparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD StudyEarly neurodegeneration in the retina of type 2 diabetic patients.Variability in photocoagulation treatment of diabetic macular oedema.Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy